221 related articles for article (PubMed ID: 1109784)
1. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
Sweeney MJ; Poore GA; Kornfeld EC; Bach NJ; Owen NV; Clemens JA
Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
3. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
4. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
[TBL] [Abstract][Full Text] [Related]
5. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
Cassell EE; Meites J; Welsch CW
Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
[No Abstract] [Full Text] [Related]
6. Is there any association between elevated serum prolactin level and mammary adenocarcinoma induced by 7,12-dimethylbenz(alpha)anthracene.
Feuer G; Kellen JA; Kovacs K
Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):435-44. PubMed ID: 807960
[TBL] [Abstract][Full Text] [Related]
7. Correlation between serum prolactin levels and incidence of mammary tumors induced by 7,12-dimethylbenz(alpha)anthracene in the rat.
Gala RR; Loginsky SJ
J Natl Cancer Inst; 1973 Aug; 51(2):593-7. PubMed ID: 4765374
[No Abstract] [Full Text] [Related]
8. Relation of prolactin and estrogen to mammary tumorigenesis in the rat.
Meites J
J Natl Cancer Inst; 1972 Apr; 48(4):1217-24. PubMed ID: 5023679
[No Abstract] [Full Text] [Related]
9. Interaction of dietary fat and the thymus in the induction of mammary tumors by 7,12-dimethylbenz(a)anthracene.
Wagner DA; Naylor PH; Kim U; Shea W; Ip C; Ip MM
Cancer Res; 1982 Apr; 42(4):1266-73. PubMed ID: 6800650
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats.
Ip C
Cancer Res; 1981 Jul; 41(7):2683-6. PubMed ID: 6788360
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Johnson ML; Levy J; Rosen JM
Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene.
Flesher JW; Sydnor KL
Cancer Res; 1971 Dec; 31(12):1951-4. PubMed ID: 5120292
[No Abstract] [Full Text] [Related]
13. Role of prolactin in the promotion of dimethylbenz[a]anthracene-induced mammary tumors by dietary fat.
Ip C; Yip P; Bernardis LL
Cancer Res; 1980 Feb; 40(2):374-8. PubMed ID: 6766086
[TBL] [Abstract][Full Text] [Related]
14. Mammary neoplasia in Sprague-Dawley or Long-Evans rats after in vitro 7, 12-dimethylbenz(alpha) anthracene.
Brown RD; Shellabarger CJ
Cancer Res; 1974 Oct; 34(10):2594-5. PubMed ID: 4414561
[No Abstract] [Full Text] [Related]
15. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
Welsch CW; Clemens JA; Meites J
J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
[No Abstract] [Full Text] [Related]
16. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
Shimkin MB; Gropper L; Thatcher D; Gruenstein M
Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
[No Abstract] [Full Text] [Related]
17. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
Heuson JC; Legros N; Heimann R
Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
[No Abstract] [Full Text] [Related]
18. Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system.
Teller MN; Kaufman RJ; Stock CC; Bowie M
Cancer Res; 1968 Feb; 28(2):368-71. PubMed ID: 5694312
[No Abstract] [Full Text] [Related]
19. Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Tan WC; Privett OS; Goldyne ME
Cancer Res; 1974 Dec; 34(12):3229-31. PubMed ID: 4429952
[No Abstract] [Full Text] [Related]
20. Prolactin stimulation of estrogen receptor in vitro in 7,12 dimethylbenz(A)anthracene-induced mammary tumor.
Sasaki GH; Leung BS
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):409-12. PubMed ID: 4369071
[No Abstract] [Full Text] [Related]
[Next] [New Search]